Skip to main content

Management of childhood asthma [State of the Art Series. Asthma in high- and low-income countries, Edited by M. Chan-Yeung. Number 5 in the series]

Buy Article:

$34.78 + tax (Refund Policy)

The guidelines for the management of childhood asthma have evolved from recommendations by experts to being evidence-based as a result of better understanding of the pathophysiology of asthma, awareness of the heterogeneity and early onset of childhood asthma and a new approach to the pharmacological management. While there are reasonably good evidence-based guidelines for the treatment of asthma in children aged over 5 years, there is a paucity of data for preschool children for the most appropriate management. Most guidelines include recommendations on diagnosis of asthma in children and pharmacological treatment according to the severity of the asthma. Environmental control is an important cornerstone of care, and allergen avoidance should be recommended for children with asthma who are known to be sensitised to the allergen. Environmental tobacco smoke remains an important trigger for worsening asthma in all children, and their parents must be encouraged to give up the habit. Educating children with asthma and their care givers on the disease and proper treatment is another vital element in the management of asthma. There remains a major problem with ensuring the implementation of guidelines in most countries. A care gap thus exists between best practice and common practice. The impact on asthma morbidity of developing and implementing guidelines requires appropriate study.

Keywords: asthma; childhood; management guidelines

Document Type: Miscellaneous

Affiliations: 1: Section of Allergy and Clinical Immunology, Department of Pediatrics and Child Health, University of Manitoba, Winnipeg Manitoba, Canada 2: Department of Paediatrics and Child Health, Stellenbosch University, Tygerberg, South Africa 3: Department of Medicine, Division of Respiratory Medicine, The University of Hong Kong, Hong Kong SAR, China

Publication date: 01 June 2006

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content